Heart rate management practices in HFrEF among Indian cardiologists: Role of beta-blocker and ivabradine-based therapy

21 May 2023 (10:08 - 11:17)

Organised by:

Abstract

Sign in to view the resources

Slides

About the speaker

Doctor Vivek Vinayak Kolapkar

Thane (India)

6 More presentations in this session

Presentation thumbnail

How low can early introduction of evidence based heart failure medications drive readmission rates?

Doctor T. Caspi (London, GB)

Abstract Slides

Presentation thumbnail

Myocardial ketone body oxidation underlies the salutary effects of SGLT2 inhibitor treatment in heart failure

Ms S. Voorrips (Groningen, NL)

Abstract Slides

Presentation thumbnail

The effect of add-on Ivabradine in patients with heart failure and reduced ejection fraction: a systematic review and meta-analysis of randomized controlled trials and real-world data

Doctor C. Liao (Tainan, TW)

Abstract Slides

Presentation thumbnail

How much can ejection fraction be improved in patients with heart failure with reduced ejection fraction (HFrEF) by the early introduction of evidence-based heart failure medication?

Doctor J. White (London, GB)

Abstract Slides

Presentation thumbnail

Early treatment of heart failure: a non-interventional observational study programme of patients with heart failure and initiated on dapagliflozin (EVOLUTION HF)

Doctor S. Adamsson Eryd (Gothenburg, SE)

Abstract Slides

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 3

The Event

Event poster

Heart Failure 2023

21 May 2023 10:08 CET

You may be interested in

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

Congress Presentation

Audience Q&A

Congress Session

Meet the Experts: summation of the science - treatment of chronic heart failure in 2023

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources